Remission Induction by Etanercept in Enthesitis related Arthritis JIA-Patients (juvenile undifferentiated Spondylarthropathy) Remissionsstudie mit Etanercept bei Kindern mit Enthesitis-assoziierter Arthritis

Trial Profile

Remission Induction by Etanercept in Enthesitis related Arthritis JIA-Patients (juvenile undifferentiated Spondylarthropathy) Remissionsstudie mit Etanercept bei Kindern mit Enthesitis-assoziierter Arthritis

Completed
Phase of Trial: Phase III

Latest Information Update: 16 Nov 2016

At a glance

  • Drugs Etanercept (Primary)
  • Indications Juvenile rheumatoid arthritis; Spondylarthritis
  • Focus Therapeutic Use
  • Acronyms REMINDER
  • Most Recent Events

    • 07 Dec 2015 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
    • 23 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top